Determination of urine thiocyanate in patients with amyotrophic lateral sclerosis

1989 ◽  
Vol 80 (5) ◽  
pp. 444-450
Author(s):  
Y. Yoshida ◽  
R. Hamada ◽  
H. Kamitsuchibashi ◽  
K. Yamamoto ◽  
M. Nakagawa ◽  
...  
2019 ◽  
Vol 59 (5) ◽  
pp. 567-576 ◽  
Author(s):  
Stefanie Schreiber ◽  
Frank Schreiber ◽  
Cornelia Garz ◽  
Grazyna Debska‐Vielhaber ◽  
Anne Assmann ◽  
...  

Open Biology ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. 200116 ◽  
Author(s):  
Sandra Anne Banack ◽  
Rachael Anne Dunlop ◽  
Paul Alan Cox

Biomarkers for amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) are currently not clinically available for disease diagnosis or analysis of disease progression. If identified, biomarkers could improve patient outcomes by enabling early intervention and assist in the determination of treatment efficacy. We hypothesized that neural-enriched extracellular vesicles could provide microRNA (miRNA) fingerprints with unequivocal signatures of neurodegeneration. Using blood plasma from ALS/MND patients and controls, we extracted neural-enriched extracellular vesicle fractions and conducted next-generation sequencing and qPCR of miRNA components of the transcriptome. We here report eight miRNA sequences which significantly distinguish ALS/MND patients from controls in a replicated experiment using a second cohort of patients and controls. miRNA sequences from patient blood samples using neural-enriched extracellular vesicles may yield unique insights into mechanisms of neurodegeneration and assist in early diagnosis of ALS/MND.


Talanta ◽  
2017 ◽  
Vol 170 ◽  
pp. 63-68 ◽  
Author(s):  
Zuzana Cieslarova ◽  
Fernando Silva Lopes ◽  
Claudimir Lucio do Lago ◽  
Marcondes Cavalcante França ◽  
Ana Valéria Colnaghi Simionato

2000 ◽  
Vol 88 (6) ◽  
pp. 2045-2053 ◽  
Author(s):  
Jeffrey M. Hausdorff ◽  
Apinya Lertratanakul ◽  
Merit E. Cudkowicz ◽  
Amie L. Peterson ◽  
David Kaliton ◽  
...  

Amyotrophic lateral sclerosis (ALS) is a disorder marked by loss of motoneurons. We hypothesized that subjects with ALS would have an altered gait rhythm, with an increase in both the magnitude of the stride-to-stride fluctuations and perturbations in the fluctuation dynamics. To test for this locomotor instability, we quantitatively compared the gait rhythm of subjects with ALS with that of normal controls and with that of subjects with Parkinson's disease (PD) and Huntington's disease (HD), pathologies of the basal ganglia. Subjects walked for 5 min at their usual pace wearing an ankle-worn recorder that enabled determination of the duration of each stride and of stride-to-stride fluctuations. We found that the gait of patients with ALS is less steady and more temporally disorganized compared with that of healthy controls. In addition, advanced ALS, HD, and PD were associated with certain common, as well as apparently distinct, features of altered stride dynamics. Thus stride-to-stride control of gait rhythm is apparently compromised with ALS. Moreover, a matrix of markers based on gait dynamics may be useful in characterizing certain pathologies of motor control and, possibly, in quantitatively monitoring disease progression and evaluating therapeutic interventions.


1959 ◽  
Vol 8 (3) ◽  
pp. 369-374 ◽  
Author(s):  
Walter F. Haberlandt

SUMMARYIn this preliminary report the question of the inheritance of amyotrophic lateral sclerosis is discussed. Through systematic search within the province of Westphalia and especially in the District of Münster, we found 251 index cases out of a population of about 250.000 neuro-psychiatric patients observed during the last 30 years. This material is being analysed from a clinical as well as from a genetic standpoint. The family study will be a basis for determination of the mode of inheritance. As for the sporadic cases of Charcot's disease, the effect of mutations must be taken into consideration.


Sign in / Sign up

Export Citation Format

Share Document